Tamayo, Aimie .

HRN: 23-61-00  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
AMPICILLIN 1GM (VIAL)
12/09/2025
12/11/2025
IVT
2g
Q6
Prom
Checking Final Appropriateness 
12/09/2025
CEFUROXIME 1.5GM (VIAL)
12/09/2025
12/09/2025
IV
1.5g
PTOR
Cs For Nrfht
Checking Final Appropriateness 
12/09/2025
CEFUROXIME 1.5GM (VIAL)
12/09/2025
12/10/2025
IV
1.5g
Q8
S/p CS
Checking Final Appropriateness 
12/10/2025
CEFUROXIME 500MG (TAB)
12/10/2025
12/17/2025
PO
500mg
BID
S/P PLTCS
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: